Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

457.38 -6.10 (-1.32%)
Streaming Delayed Price Updated: 2:03 PM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Vertex Pharmaceuticals

< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
63 64 Next >
News headline image
A Bull Market Is Coming. Here Are 3 Stocks You'll Absolutely Want to Own. ↗
These stocks are already big winners in 2023 and should keep their momentum going in a new bull market. 
Via The Motley Fool
News headline image
Where Will Vertex Pharmaceuticals Be in 10 Years? ↗
Vertex shares have soared 400% over the past decade. 
Via The Motley Fool
News headline image
3 No-Brainer Growth Stocks to Buy in December ↗
No analysis paralysis is required with these great stocks. 
Via The Motley Fool
News headline image
Got $5,000? These Are 2 of the Best Growth Stocks to Buy Right Now ↗
The one thing these two stocks have in common is tremendous growth prospects. 
Via The Motley Fool
News headline image
5 Top Stocks to Buy Before 2024 ↗
These stocks have room to run -- next year and over the long term. 
Via The Motley Fool
News headline image
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals? ↗
It's not as long a shot as some might think. 
Via The Motley Fool
News headline image
Is Vertex Pharmaceuticals Stock a Buy Now? ↗
The company is close to another breakthrough. 
Via The Motley Fool
News headline image
How Is The Market Feeling About Vertex Pharmaceuticals? ↗
 
Via Benzinga
News headline image
Looking for Growth? 2 Top Stocks to Buy Hand Over Fist ↗
These stocks offer enormous long-term growth potential. 
Via The Motley Fool
News headline image
3 Biotech Stocks That Could Be Multibaggers in the Making ↗
Uncover investment opportunities with biotech stocks representing firms developing critical breakthroughs in treatments. 
Via InvestorPlace
News headline image
3 Top-Rated Biotech Stocks That Analysts Are Loving Now ↗
Investing in biotech stocks can be tricky, but analysts have bullish outlooks on these three, promising companies. 
Via InvestorPlace
News headline image
Biotech And Healthcare Portfolio Playbook For December 2023/24 ↗
We are having a great but choppy market recovery over the past four weeks and it looks like it should continue through to the next earnings cycle in January. 
Via Talk Markets
News headline image
5 Stocks You Can Confidently Invest $500 In Right Now ↗
These companies could significantly grow your investment over the long haul. 
Via The Motley Fool
News headline image
2 Healthcare Stocks That Could Help Set You Up for Life ↗
Both companies are leaders in their fields. 
Via The Motley Fool
News headline image
Investing in These 3 Stocks Now Could Make You a Millionaire Retiree ↗
These innovators should have tremendous long-term growth prospects. 
Via The Motley Fool
News headline image
4 First-Class Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip ↗
The innovation-fueled Nasdaq Composite is still 11% below its all-time high, which means bargains abound for opportunistic investors. 
Via The Motley Fool
Topics Stocks
News headline image
Prediction: 3 Stocks That Could Trounce the Market ↗
These stocks have what it takes to be huge winners over the next several years. 
Via The Motley Fool
News headline image
3 Biotech Stocks That Could Be Millionaire Makers ↗
Many biotech stocks offer exciting long-term growth prospects. 
Via The Motley Fool
News headline image
Here's How Much $100 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
2 Beaten-Down Growth Stocks That Could Rocket 42% to 67% Higher, According to Wall Street ↗
Investment bank analysts are pounding the table on these stocks, but are they right for your portfolio? 
Via The Motley Fool
News headline image
Could Investing $10,000 In CRISPR Therapeutics Stock Make You a Millionaire? ↗
The stock is trading below its peak, reached a couple of years ago. 
Via The Motley Fool
News headline image
Barron's Weekend Stock Picks: Disney, Palantir And Cisco's Calamitous Outlook ↗
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read. 
Via Benzinga
News headline image
Why CRISPR Therapeutics Stock Is Jumping Again Today ↗
The stock continues to enjoy momentum from a key regulatory approval. 
Via The Motley Fool
News headline image
Williams-Sonoma, Uber And 2 Other Stocks Insiders Are Selling ↗
The Nasdaq 100 closed higher by 0.1% on Thursday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
News headline image
Crispr Surges After Winning The First-Ever Approval For A CRISPR-Based Gene-Editing Drug ↗
The drug will sell under the brand name Casgevy in the UK for two blood diseases. 
Via Investor's Business Daily
News headline image
What's Going On With Crispr Therapeutics Stock Thursday? ↗
CRISPR Therapeutics AG (NASDAQ: CRSP) shares are trading higher Thursday after the company announced regulatory authorization of the first CRISPR/Cas9 gene- 
Via Benzinga
News headline image
CRISPR Therapeutics (CRSP) Stock Jumps as U.K. Authorizes Gene Therapy ↗
CRSP stock is up on U.K. authorization for its gene therapy treatment for sickle cell anemia. CRISPR hopes for FDA authorization next spring. 
Via InvestorPlace
News headline image
UK Approves First Crispr Gene Edited Therapy For Sickle Cell Disease, Beta Thalassemia ↗
The U.K. 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Right Now Could Be a Once-in-a-Generation Opportunity to Buy These Cathie Wood Stocks ↗
You might not get a better chance to invest in these disruptive companies. 
Via The Motley Fool
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
63 64 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.